TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer
(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.
Read more